Buckhead Capital Management Has Increased Global Brass & Coppr Hldgs I (BRSS) Position; Tandem Diabetes Care (TNDM) Has 0.55 Sentiment

November 15, 2017 - By wolcottdaily

Tandem Diabetes Care, Inc. is a medical device company. The company has market cap of $26.01 million. The Firm is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. It currently has negative earnings. The Firm makes and sells three insulin pump products, which include t:slim Insulin Delivery System , t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4).

Buckhead Capital Management Llc increased Global Brass & Coppr Hldgs I (BRSS) stake by 144.87% reported in 2017Q2 SEC filing. Buckhead Capital Management Llc acquired 12,220 shares as Global Brass & Coppr Hldgs I (BRSS)’s stock declined 8.67%. The Buckhead Capital Management Llc holds 20,655 shares with $631,000 value, up from 8,435 last quarter. Global Brass & Coppr Hldgs I now has $710.78 million valuation. It is 0.00% or $0 reaching $32.45 per share. It is down 14.72% since November 15, 2016 and is uptrending. It has underperformed by 1.98% the S&P500.

Investors sentiment decreased to 1.28 in 2017 Q2. Its down 0.05, from 1.33 in 2017Q1. It dived, as 24 investors sold BRSS shares while 37 reduced holdings. 20 funds opened positions while 58 raised stakes. 20.83 million shares or 1.03% more from 20.62 million shares in 2017Q1 were reported. First Advisors Lp owns 145,244 shares. Zurcher Kantonalbank (Zurich Cantonalbank) reported 910 shares or 0% of all its holdings. Art Ltd Llc invested in 0.03% or 16,635 shares. Numeric Investors Lc has invested 0.04% in Global Brass and Copper Holdings Inc (NYSE:BRSS). Great West Life Assurance Com Can has 2,948 shares for 0% of their portfolio. D E Shaw & invested 0.01% in Global Brass and Copper Holdings Inc (NYSE:BRSS). 207,182 are owned by Tiaa Cref Management Llc. Hillcrest Asset Mngmt owns 1.92% invested in Global Brass and Copper Holdings Inc (NYSE:BRSS) for 340,979 shares. Clarivest Asset Management Limited Co holds 380,022 shares. Kennedy Capital Incorporated stated it has 0.14% in Global Brass and Copper Holdings Inc (NYSE:BRSS). Ameritas Inv Prtn owns 1,904 shares or 0% of their US portfolio. 31,300 are held by California Employees Retirement. Globeflex Capital LP holds 0.06% or 7,929 shares in its portfolio. Geode Cap Mngmt Ltd Liability Company holds 0% in Global Brass and Copper Holdings Inc (NYSE:BRSS) or 268,600 shares. Secor Advsrs Limited Partnership holds 0.3% in Global Brass and Copper Holdings Inc (NYSE:BRSS) or 108,151 shares.

Analysts await Tandem Diabetes Care Inc (NASDAQ:TNDM) to report earnings on March, 14. They expect $-1.77 earnings per share, up 63.13% or $3.03 from last year’s $-4.8 per share. After $-3.09 actual earnings per share reported by Tandem Diabetes Care Inc for the previous quarter, Wall Street now forecasts -42.72% EPS growth.

About 118 shares traded. Tandem Diabetes Care Inc (TNDM) has declined 86.78% since November 15, 2016 and is downtrending. It has underperformed by 103.48% the S&P500.

Dafna Capital Management Llc holds 0.41% of its portfolio in Tandem Diabetes Care Inc for 724,286 shares. Shaker Investments Llc Oh owns 139,560 shares or 0.08% of their US portfolio. Moreover, Wasatch Advisors Inc has 0.04% invested in the company for 3.17 million shares. The New York-based Element Capital Management Llc has invested 0.03% in the stock. Falcon Point Capital Llc, a California-based fund reported 261,412 shares.

Ratings analysis reveals 50% of Tandem Diabetes Care’s analysts are positive. Out of 2 Wall Street analysts rating Tandem Diabetes Care, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $3.5 while the high is $9.0. The stock’s average target of $6.25 is 143.19% above today’s ($2.57) share price. TNDM was included in 2 notes of analysts from November 2, 2016. The company was downgraded on Wednesday, November 2 by Stifel Nicolaus. On Wednesday, November 2 the stock rating was maintained by Deutsche Bank with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: